Press release
The Impact Of Increasing Leukemia Prevalence On The Leukemia Therapeutics Market: Key Factor Driving The Growth In The Leukemia Therapeutics Market
Leukemia Therapeutics
What Is the Expected Leukemia Therapeutics Market Size During the Forecast Period?
In recent times, the market size for leukemia therapeutics has seen robust growth. It is projected to increase from $17.57 billion in 2024 to $18.85 billion in 2025, signaling a compound annual growth rate (CAGR) of 7.3%. Factors which have contributed to this trend during the historic period include a surge in the elderly population, advancements in diagnostics facilitating earlier detection of leukemia, a rise in leukemia cases, increased investment in research and development, and broadened approaches towards personalized medicine.
The market size of leukemia therapeutics is predicted to experience substantial growth in the upcoming years, reaching $25.91 billion by 2029 with a compound annual growth rate (CAGR) of 8.3%. This projected expansion during the forecast period can be credited to the creation of new immunotherapies for leukemia, the increasing emphasis on precision medicine for leukemia treatment, broadening of existing leukemia treatment areas, heightened employment of gene therapies, and improvements in supportive care for leukemia patients. Significant trends expected during the forecast period comprise the incorporation of biomarker-driven approaches, the emergence of combination therapies for amplified effectiveness, concentration on monitoring minimal residual disease, rising utilization of car-t cell therapies, and the investigation of targeted therapies based on different leukemia subtypes.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6358
What Are the High-Growth Segments in the Leukemia Therapeutics Market?
The leukemia therapeutics market covered in this report is segmented -
1) By Treatment Type: Chemotherapy, Immunotherapy, Targeted Therapy, Other Treatments
2) By Type Of Leukemia: Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Other Type Of Leukemia
3) By Molecule Type: Small Molecules, Biologics
4) By End-Users: Hospitals, Homecare, Specialty Clinics, Other End-Users
Subsegments:
1) By Chemotherapy: Alkylating Agents, Antimetabolites, Plant Alkaloids, Corticosteroids
2) By Immunotherapy: Monoclonal Antibodies, CAR T-Cell Therapy, Immune Checkpoint Inhibitors, Vaccines
3) By Targeted Therapy: Tyrosine Kinase Inhibitors (TKIs), BCL-2 Inhibitors, IDH Inhibitors, Other Targeted Agents
4) By Other Treatments: Radiation Therapy, Stem Cell Transplantation, Supportive Care Treatments
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6358&type=smp
What Key Drivers Are Expected to Influence Future Leukemia Therapeutics Market Growth?
The leukemia therapeutics market is growing due to an increasing number of leukemia cases. Leukemia, a type of blood cancer that originates in the bone marrow, causes uncontrolled growth of blood cells. The global accessibility to leukemia treatment and the expanding treatment options contribute to the rise in demand for leukemia therapeutics. As per the American Cancer Society's report released in January 2023, around 59,610 new leukemia cases of all kinds and approximately 23,710 deaths related to all types of leukemia are predicted in the United States in 2023. Additionally, forecasts suggest around 20,380 new incidences of acute myeloid leukemia (AML) and roughly 11,310 related deaths within the same year. Thus, the growing occurrence rate of leukemia is leading to the expansion of the leukemia therapeutics market.
Which Companies Hold the Largest Share Across Different Leukemia Therapeutics Market Segments?
Major companies operating in the leukemia therapeutics market include Novartis International AG, AbbVie Inc., Bristol Myers Squibb Company, F. Hoffmann-La Roche AG, Sanofi S. A., Agios Pharmaceuticals, Amgen Inc., Argenx SE, Astellas Pharma Inc., BioLineRx Ltd., Cellerant Therapeutics Inc., Daiichi Sankyo Company Limited, Forma Therapeutics Inc., Gilead Sciences Inc., Incyte Corporation, Jazz Pharmaceuticals plc, Johnson & Johnson, Mirati Therapeutics Inc., Molecular Templates Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc., Seattle Genetics Inc., Stemline Therapeutics Inc., Sunesis Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, TG Therapeutics Inc., Allogene Therapeutics Inc., Blueprint Medicines Corporation, Karyopharm Therapeutics Inc., Verastem Oncology Inc.
What Trends Are Driving Growth in The Leukemia Therapeutics Market?
Leading corporations within the leukemia therapeutics market are utilizing a strategic alliance strategy to assist their venture in successfully launching and marketing their premier advanced cancer treatment in the United States. These strategic alliances involve businesses capitalizing on each other's abilities and resources for reciprocal advantage and accomplishment. For example, in February 2023, Xspray Pharma AB, a biotechnology firm based in Sweden, formed a partnership with EVERSANA, a US firm providing commercial services to the life sciences sector. The objective of this collaboration is to streamline the U.S. introduction and marketing of the company's inaugural innovative cancer remedy, Dasynoc, designed for the treatment of chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL). Xspray Pharma will maintain financial and strategic command whilst assigning EVERSANA exclusive marketing rights to back the Dasynoc launch, slated for the latter half of 2023.
Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/leukemia-therapeutics-global-market-report
What Are the Emerging Geographies for The Leukemia Therapeutics Market Growth?
North America was the largest region in the leukemia therapeutics market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the leukemia therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Leukemia Therapeutics Market?
2. What is the CAGR expected in the Leukemia Therapeutics Market?
3. What Are the Key Innovations Transforming the Leukemia Therapeutics Industry?
4. Which Region Is Leading the Leukemia Therapeutics Market?
Why This Report Matters:
Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.
Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.
Efficient Research: Quickly identify market growth, leading players, and major segments.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The Impact Of Increasing Leukemia Prevalence On The Leukemia Therapeutics Market: Key Factor Driving The Growth In The Leukemia Therapeutics Market here
News-ID: 3961190 • Views: …
More Releases from The Business Research Company
Major Growth Driver Identified in 2025 Phosphate Rock Market: Phosphate Rock Mar …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Phosphate Rock Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent years, there has been noteworthy expansion in the size of the phosphate rock market. The market is projected to escalate from $26.64 billion in 2024 to $28.09 billion in 2025, representing a compound…
Pharmaceutical Industry Surge Propels Growth In The Pharmaceutical Glass Packagi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pharmaceutical Glass Packaging Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
There has been significant growth in the size of the pharmaceutical glass packaging market in the last few years. The market is expected to progress from a worth of $14.94 billion in 2024 to…
Pesticide And Other Agricultural Chemicals Market Expansion Continues, with Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pesticide And Other Agricultural Chemicals Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size for pesticides and other agricultural chemicals has witnessed a swift expansion. The forecast suggests an increase from $117.54 billion in 2024 to $131.78 billion in 2025,…
Comprehensive Personal Care Shower And Bath Market Forecast 2025-2034: Growth Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Personal Care Shower And Bath Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the personal care shower and bath market has witnessed robust growth. It is set to expand from its value of $62.52 billion in 2024 to $66.71 billion in 2025,…
More Releases for Leukemia
T-Cell Prolymphocytic Leukemia Pipeline: 5+ Companies Advancing Novel Therapeuti …
The therapeutic landscape for T-Cell Prolymphocytic Leukemia (T-PLL), a rare and aggressive form of mature T-cell leukemia, is witnessing growing research interest as biotech and pharma innovators aim to overcome the limitations of current treatment approaches. Characterized by rapid disease progression and poor prognosis, T-PLL presents substantial clinical challenges, including limited therapeutic options and high relapse rates following conventional chemotherapy and alemtuzumab-based regimens.
In response, leading players such as Ascentage Pharma,…
The Impact Of Increasing Leukemia Prevalence On The Leukemia Therapeutics Market …
"What combination of drivers is leading to accelerated growth in the leukemia therapeutics market?
Leukemia therapeutics market is witnessing a surge due to the escalating incidence rates of leukemia. Leukemia, a blood cancer initiating in the bone marrow, leads to an unchecked multiplication of blood cells. The rise in global accessibility to medical solutions for leukemia patients, and an ever-increasing number of treatment alternatives, have fueled the demand for leukemia therapeutics.…
Major Force in the Chronic Myeloid Leukemia Treatment Market 2025: Rising Incide …
How Will the Chronic Myeloid Leukemia Treatment Market Grow, and What Is the Projected Market Size?
The chronic myeloid leukemia treatment market has seen strong growth in recent years. It is expected to grow from $9.2 billion in 2024 to $9.76 billion in 2025, with a CAGR of 6.2%. This increase can be attributed to the rising incidence of chronic myeloid leukemia, greater awareness of cancer treatments, government initiatives, and increased…
Acute Myeloid Leukemia Pipeline Unveiled: Pioneering Efforts in Acute Myeloid Le …
The Acute Myeloid Leukemia Pipeline Insight 2023 report by DelveInsight offers a thorough global overview of Acute Myeloid Leukemia treatments, including those already in the market, as well as those in different phases of clinical development. Prominent pharmaceutical firms are dedicated to progressing the pipeline landscape and fostering the potential growth of Acute Myeloid Leukemia therapeutic advancements.
Key Takeaways from the Acute Myeloid Leukemia Pipeline Report
• DelveInsight's Acute Myeloid Leukemia pipeline…
Leukemia Therapeutics Market - Revolutionizing Leukemia Care: Cutting-Edge Thera …
Newark, New Castle, USA: The "Leukemia Therapeutics Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Leukemia Therapeutics Market: https://www.growthplusreports.com/report/leukemia-therapeutics-market/7759
This latest report researches the industry structure, sales, revenue,…
Acute Myeloid Leukemia Market - Shattering Limits, Renewing Hope: Advancing the …
Newark, New Castle, USA - new report, titled Acute Myeloid Leukemia Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Acute Myeloid Leukemia market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Acute Myeloid Leukemia market. The report offers an overview of…
